NEW YORK (GenomeWeb News) – Deloitte Consulting late on Tuesday announced it has acquired Recombinant Data for an undisclosed amount.

Based in Newton, Mass., Recombinant Data provides healthcare IT solutions and research data management and analytics. Its products and services, Deloitte Consulting said, are used to advance personalized medicine, translational research — including genomics, phenomics, and proteomics — and healthcare performance management.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."